Skip to main content

Table 1 Characteristics of the studies included in the meta-analysis

From: Mobile health in the management of type 1 diabetes: a systematic review and meta-analysis

Author Year, Country Study types Number of participants (I/C) Age years (I/C) Sex(M/F) Diabetes duration (I/C) Intervention type HbA1c at baseline (I/C) HbA1c at follow-up (I/C) Follow-up (months)
I C
Han, Y 2015, USA RCT 20 (10/10) 13.8±1.874/12.9±2.183 4/6 5/5 6±4.662/7.3±3.164 mobile text message 8.60±0.867/8.78±0.728 8.23±1.370/8.57±0.786 3-4
Berndt 2014, Germany RCT 68 (34/34) 12.9±2.0/13.2±2.9 21/13 20/14 5.0±3.7/5.3±4.0 mobile applications 8.84±1.71/8.96±2.23 8.12±1.10/7.99±1.26 3
Charpentier 2012, France RCT 121 (60/61) 32.9±11.7/36.8±14.1 23/37 21/40 17.6±8.9/16.9±10.5 mobile applications 9.19±1.14/8.91±0.90 8.63±1.07/9.10±1.16 6
David 2009, USA RCT 40 (22/18) 17.7±3.0/18.2±2.3 9/13 9/9 9.0±4.2/9.5±5.6 mobile text message 8.9±1.7/8.6±0.9 8.7±1.5/8.8±0.9 3
Franklin 2008, Scotland RCT 60 (33/27) 14.1 (11.7-15.6)/12.7 (10.5-14.8) 15/18 17/10 4.8 (2.6-8.6)/3.2 (1.7-6.7) mobile text message 9.8±1.8/10.2±1.6 10.1±1.7/10.3±1.7 12
Rossi 2013, Italy RCT 127 (63/64) 38.4±10.3/34.3±10.0 29/34 31/33 16.2±10.0/15.0±8.4 mobile applications 8.4±0.79/8.5±0.8 7.9±0.79/8.1±0.8 6
Kirwan 2013, Australia RCT 72 (36/36) 35.97±10.67/34.42±/10.26 19/17 9/27 19.69±9.64/18.19±9.77 mobile applications 9.08±1.18/8.47±0.86 7.80±0.75/8.58±1.16 9
Rossi 2010, Italy RCT 130 (67/63) 35.4±9.5/36.1±9.4 30/37 26/37 17.1±10.3/15.8±10.7 mobile applications 8.2±0.8/8.4±0.7 7.8±0.8/7.9±1.1 6
  1. Note. I/C intervention group/Control group, RCT randomized controlled trial, IQR interquartile range, M/F male/female
  2. Values are Mean ± SD for continuous normal distribution, Median (IQR) and Median (range) for continuous skewed distribution
  3. Mobile text message: Using short message to intervene patients; Mobile applications: Use mobile phone applications to interact with patients and educate patients
  4. Table 1 describes the basic features of the literature